GREM1 and non-small cell lung carcinoma: GREM1-positive NSCLC patients had much higher levels of CD3+ T and sharply lower levels of CD8+ T than GREM1-negative patients (Bao et al. 2023), suggesting its expression was related to immune cell infiltration.